Enduring multilineage hematopoiesis reconstituted from transgene-expressing cells after transplantation with transduced bone marrow
Days After Transplant . | Mouse# . | % Ly5.2+ . | % NGFR+ on Ly-5.2+ WBCs . | % NGFR+ On . | |||||
---|---|---|---|---|---|---|---|---|---|
Total . | Gr-1+ . | Mac-1+ . | B220+ . | CD3e+ . | RBCs . | Platelets . | |||
Experiment 1, day 174 | BA.1 control | 98.2 ± 1.3 | 0.3 ± 0.0 | 1.1 ± 0.3 | 1.1 ± 0.2 | 0.8 ± 0.2 | 1.7 ± 0.6 | 0 | 0 |
Mock | 94.8 ± 1.1 | 0.3 ± 0.1 | 1.0 ± 0.4 | 0.9 ± 0.2 | 1.2 ± 0.3 | 1.0 ± 0.9 | 0 | 0 | |
1171 (n = 8) | 93.8 ± 1.0 | 12.6 ± 9.7 | 36.1 ± 24.9 | 28.2 ± 19.5 | 13.2 ± 6.6 | 11.6 ± 7.1 | 10.6 ± 21.0 | 8.7 ± 14.8 | |
1171 Range | 92.7-95.5 | 3.7-33.6 | 5.1-72.3 | 6.3-61.5 | 2.9-24.3 | 3.5-24.3 | 0.9-62.3 | 0.8-44.7 | |
Experiment 2, day 161 | BA.1 control | 94.2 ± 8.6 | 0.3 ± 0.0 | 0.8 ± 0.3 | 0.8 ± 0.2 | 0.5 ± 0.0 | 0.6 ± 0.2 | 0 | 0 |
Mock | 95.6 ± 0.9 | 0.4 ± 0.1 | 1.0 ± 0.4 | 0.9 ± 0.3 | 0.6 ± 0.2 | 0.5 ± 0.2 | 0 | 0 | |
1171 (n = 7) | 90.0 ± 5.7 | 20.2 ± 9.2 | 51.6 ± 12.5 | 44.0 ± 12.0 | 13.2 ± 8.5 | 14.5 ± 7.3 | 14.1 ± 14.0 | 15.7 ± 11.7 | |
1171 Range | 79.2-94.8 | 11.9-38.9 | 35.4-73.1 | 30.2-67.1 | 7.2-30.4 | 7.4-28.1 | 4.1-39.9 | 6.6-35.6 | |
Experiment 2, day 249 | BA.1 control | 98.5 | 0.4 | 0.2 | 0.6 | 0.2 | 0.5 | 0 | 0 |
B6SJL | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.1 | |
Mock | 96.1 | 0.3 | 0.3 | 1.2 | 0.5 | 0.2 | 0 | 0.1 | |
#211 | 90.2 | 24.7 | 71.9 | 57.8 | 9.5 | 16.8 | 8.6 | 10.3 | |
#213 | 86.4 | 44.3 | 65.2 | 47.4 | 37.4 | 20.3 | 17.9 | 19.8 | |
#217 | 92.4 | 26.6 | 53.7 | 47.3 | 13.1 | 17.4 | 17.1 | 16.9 |
Days After Transplant . | Mouse# . | % Ly5.2+ . | % NGFR+ on Ly-5.2+ WBCs . | % NGFR+ On . | |||||
---|---|---|---|---|---|---|---|---|---|
Total . | Gr-1+ . | Mac-1+ . | B220+ . | CD3e+ . | RBCs . | Platelets . | |||
Experiment 1, day 174 | BA.1 control | 98.2 ± 1.3 | 0.3 ± 0.0 | 1.1 ± 0.3 | 1.1 ± 0.2 | 0.8 ± 0.2 | 1.7 ± 0.6 | 0 | 0 |
Mock | 94.8 ± 1.1 | 0.3 ± 0.1 | 1.0 ± 0.4 | 0.9 ± 0.2 | 1.2 ± 0.3 | 1.0 ± 0.9 | 0 | 0 | |
1171 (n = 8) | 93.8 ± 1.0 | 12.6 ± 9.7 | 36.1 ± 24.9 | 28.2 ± 19.5 | 13.2 ± 6.6 | 11.6 ± 7.1 | 10.6 ± 21.0 | 8.7 ± 14.8 | |
1171 Range | 92.7-95.5 | 3.7-33.6 | 5.1-72.3 | 6.3-61.5 | 2.9-24.3 | 3.5-24.3 | 0.9-62.3 | 0.8-44.7 | |
Experiment 2, day 161 | BA.1 control | 94.2 ± 8.6 | 0.3 ± 0.0 | 0.8 ± 0.3 | 0.8 ± 0.2 | 0.5 ± 0.0 | 0.6 ± 0.2 | 0 | 0 |
Mock | 95.6 ± 0.9 | 0.4 ± 0.1 | 1.0 ± 0.4 | 0.9 ± 0.3 | 0.6 ± 0.2 | 0.5 ± 0.2 | 0 | 0 | |
1171 (n = 7) | 90.0 ± 5.7 | 20.2 ± 9.2 | 51.6 ± 12.5 | 44.0 ± 12.0 | 13.2 ± 8.5 | 14.5 ± 7.3 | 14.1 ± 14.0 | 15.7 ± 11.7 | |
1171 Range | 79.2-94.8 | 11.9-38.9 | 35.4-73.1 | 30.2-67.1 | 7.2-30.4 | 7.4-28.1 | 4.1-39.9 | 6.6-35.6 | |
Experiment 2, day 249 | BA.1 control | 98.5 | 0.4 | 0.2 | 0.6 | 0.2 | 0.5 | 0 | 0 |
B6SJL | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.1 | |
Mock | 96.1 | 0.3 | 0.3 | 1.2 | 0.5 | 0.2 | 0 | 0.1 | |
#211 | 90.2 | 24.7 | 71.9 | 57.8 | 9.5 | 16.8 | 8.6 | 10.3 | |
#213 | 86.4 | 44.3 | 65.2 | 47.4 | 37.4 | 20.3 | 17.9 | 19.8 | |
#217 | 92.4 | 26.6 | 53.7 | 47.3 | 13.1 | 17.4 | 17.1 | 16.9 |
Data for day 174 or 161 represent the mean percentage ± SD of Ly-5.2+ or NGFR+ cells in peripheral blood of mice after transplantation of bone marrow cells transduced with the 1171 vector. Data for day 249 show the percentage of Ly-5.2+ or NGFR+ cells in various peripheral blood cell lineages of 3 mice. All abbreviations are as in Figure 1.